A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053 AM1)



Status:Archived
Conditions:Osteoporosis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010
End Date:May 2014

Use our guide to learn which trials are right for you!

A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) in the Treatment of Men With Osteoporosis Treated With Vitamin D and Calcium


The purpose of this study is to test the hypothesis that treatment with odanacatib will
result in increased BMD (bone mineral density) compared to treatment with placebo. This
study will also evaluate the safety and efficacy of odanacatib for male osteoporosis
patients.


The original study was divided into two parts, with the primary analysis of endpoints to
occur at 24 months and the patients will then remain in the study for an additional 12
months (Part 2). Amendment 1 of the protocol removed the additional 12 month period and the
Month 36 BMD analysis was deleted.


We found this trial at
9
sites
Falls Church, Virginia 22042
?
mi
from
Falls Church, VA
Click here to add this to my saved trials
1200 Old York Road
Abington, Pennsylvania 19001
(215) 481–2000
Abington Memorial Hospital Abington Memorial Hospital (AMH) is a 665-bed, regional referral center and teaching...
?
mi
from
Abington, PA
Click here to add this to my saved trials
?
mi
from
Abington, PA
Click here to add this to my saved trials
?
mi
from
Albuquerque,, NM
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Falls Church, VA
Click here to add this to my saved trials
?
mi
from
Marshfield, WI
Click here to add this to my saved trials
New Britain, Connecticut 06052
?
mi
from
New Britain, CT
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials